CITI/CALL/FRESENIUS MEDICAL CARE/50/0.1/19.12.24 Share Price

Warrant

DE000KH2C6T1

Market Closed - Deutsche Boerse AG 18:27:44 31/05/2024 BST
0.08 EUR -.--% Intraday chart for CITI/CALL/FRESENIUS MEDICAL CARE/50/0.1/19.12.24
Current month-33.33%
1 month-33.33%
Date Price Change
31/05/24 0.08 -.--%
30/05/24 0.08 +14.29%
29/05/24 0.07 -22.22%
28/05/24 0.09 +12.50%
27/05/24 0.08 -11.11%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 06:27 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Citi Citi
WKN KH2C6T
ISINDE000KH2C6T1
Date issued 19/01/2023
Strike 50
Maturity 19/12/2024 (201 Days)
Parity 10 : 1
Emission price 0.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.76
Lowest since issue 0.043

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.18 EUR
Average target price
39.92 EUR
Spread / Average Target
+1.89%
Consensus